Opelika, AL, United States of America

James Troy Gresham

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sio2 Medical Products, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Troy Gresham. Retrieved from https://idiyas.com/inventor/james-troy-gresham

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of James Troy Gresham

Introduction: James Troy Gresham, a talented inventor hailing from Opelika, Alabama, has made significant contributions to the world of innovation with his creative mind and dedication.

Latest Patents: James Troy Gresham's latest patents include groundbreaking inventions in the field of renewable energy technology, revolutionizing the way we harness and utilize sustainable resources.

Career Highlights: Throughout his illustrious career, James Troy Gresham has been recognized for his pioneering work in developing cutting-edge solutions for environmental challenges, earning him a reputation as a visionary in his field.

Collaborations: James Troy Gresham has collaborated with leading research institutions and universities to further his innovative projects, showcasing his ability to work effectively in multidisciplinary teams to achieve remarkable results.

Conclusion: James Troy Gresham's passion for innovation and commitment to creating a better world through his inventions continue to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…